Case study

Conquering the oncology marketspace

We are experts in hematology and oncology, especially in value and access communications. Our team of clinical experts and board-certified oncology pharmacists have a deep understanding of the complexities of cancer care and the unique challenges facing novel therapies like CAR-T and cell and gene therapies.

Oncology expertise to support market access for life-saving therapies

We are experts in hematology and oncology, especially in value and access communications. Our team of clinical experts and board-certified oncology pharmacists have a deep understanding of the complexities of cancer care and the unique challenges facing novel therapies like CAR-T and cell and gene therapies.
* Available in English only.

Related resources

Webinar

Building HTA‑ready evidence with AI‑enabled early modeling

Article

How MFN is reshaping global market access
Post-launch checklist

Checklist

Post‑launch checklist: Five key factors for sustained post‑launch success